{"SPADE_N_07371": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07371", "Peptide Name": "Rufomycin-1, Rufomycin B", "Source": "Bacteria", "Family": "", "Gene": "Not found", "Sequence": "XXXAXLX", "Sequence Length": 7, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C9H8N2O-2", "Mass": 76938, "PI": 6.11, "Net Charge": 0, "Hydrophobicity": 0.8, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Literature": [{"Title": "Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M abscessus", "Pubmed ID": "30602512", "Reference": "Agents Chemother. 2019 Feb 26;63(3)e02204-18.", "Author": "Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine JB, Jin YY, Cheng J, Lee H, Suh JW, Duc NM, Paik S, Choe JH, Jo EK, Chang CL, Lee JS, Jaki BU, Pauli GF, Franzblau SG, Cho S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30602512"}], "Frequent Amino Acids": "XAL", "Absent Amino Acids": "CDEFGHIKMNOPQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 1, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00017", "Similarity": 1.0, "Sequence": "TTWPCATVGVSVALCPTTKCTSQC"}, {"SPADE_ID": "SPADE_N_00019", "Similarity": 1.0, "Sequence": "GTPLALLGGAATGVIGYISNQTCPTTACTRAC"}, {"SPADE_ID": "SPADE_N_00020", "Similarity": 1.0, "Sequence": "TTPACFTIGLGVGALFSAKFC"}]}}}